Waters new Rapid Screening-DSC enables up to 24x faster thermal stability testing at ultra-low sample volumes for antibody drugs

FHS
July 24, 2024
11:36 am

Waters Corporation announced today the global release of the TA Instruments™ Rapid Screening-Differential Scanning Calorimeter (TA Instruments RS-DSC), designed for biopharmaceutical developers. The TA Instruments RS-DSC is a high-throughput DSC for precise thermal stability testing of high-concentration biologic formulations specifically for antibody drugs and engineered proteins

Inside Canary Wharf’s infectious disease testing facility – Pharmaceutical Technology

hVIVO’s new facility opened this year. Image credit: hVIVO. Nestled between J P Morgan’s London headquarters and the Mastercard office in Canary Wharf, London, is

July 18, 2024

Stryker adds minimally invasive bunion device to fast-growing extremities portfolio

Dive Brief: Stryker has introduced a new minimally invasive system for treating bunions, expanding the portfolio of devices it acquired in its $4 billion takeover

September 21, 2023

FDA grants fast track status for iECURE’s OTC deficiency therapy

The study of ECUR-506 will enrol newborn males aged up to seven months diagnosed with severe neonatal onset OTC deficiency. Credit: Gorodenkoff / Shutterstock.com. The

May 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.